Expression of AQP5 and AQP8 in human colorectal carcinoma and their clinical significance by Wei Wang et al.
WORLD JOURNAL OF 
SURGICAL ONCOLOGY 
Wang et al. World Journal of Surgical Oncology 2012, 10:242
http://www.wjso.com/content/10/1/242RESEARCH Open AccessExpression of AQP5 and AQP8 in human
colorectal carcinoma and their clinical
significance
Wei Wang1†, Qing Li2†, Tao Yang1, Guang Bai1, Dongsheng Li1, Qiang Li1 and Hongzhi Sun1*Abstract
Background: The aquaporins (AQPs) are a family of small membrane transport proteins whose overexpression has
been implicated in tumorigenesis. However, the expression of AQP5 and AQP8 in colorectal cancer and the clinical
significance remain unexplored. This study aimed to detect the expression of AQP5 and AQP8 in clinical samples of
colorectal cancer and analyze the correlations of their expression with the clinicopathological features of colorectal
cancer.
Methods: Forty pairs of colorectal cancer tissue and paraneoplastic normal tissue were obtained at the time of
surgery from patients with colorectal cancer. The expression of AQP5 and AQP8 was detected by
immunohistochemical staining and reverse transcriptase polymerase chain reaction.
Results: AQP5 was mainly expressed in colorectal carcinoma cells and barely expressed in paraneoplastic normal
tissues. By contrast, AQP8 was mainly expressed in paraneoplastic normal tissues and barely expressed in colorectal
carcinoma cells. AQP5 expression was not significantly associated with the sex or age of the patient with colorectal
cancer (P>0.05), but was closely associated with the differentiation, tumor-nodes-metastasis stage and distant
lymph node metastasis of colorectal carcinoma (P<0.05).
Conclusions: AQP5 might be a novel prognostic biomarker for patients with colorectal cancer.
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Colorectal carcinoma (CRC) is one of the most common
malignancies in the world. Despite the advances in the
diagnosis and treatment of CRC in the past several
years, the overall prognosis for patients with CRC
remains poor [1]. Therefore, many investigations have
focused on the identification of novel prognostic and
predictive biomarkers for CRC and a variety of biomar-
kers that could predict the survival of CRC have been
reported recently [2-6].
It is well-known that tumor growth, development, in-
vasion and metastasis depend on nutrient supply and* Correspondence: zaishun5@yahoo.com
†Equal contributors
1Department of General Surgery, The First Affiliated Hospital, Liaoning
Medical University, No 2,5th Duan, People’s Street, Guta District, Jinzhou
121001, China
Full list of author information is available at the end of the article
© 2012 Wang et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the ormetabolism and water molecules play an important role
in the modulation of the tumor microenvironment and
tumor metabolism. The aquaporins (AQPs) consist of a
family of small membrane transport proteins. Up to
now, 13 members of the AQPs have been identified in
human, which can be subdivided into two groups based
on the basis of their permeability: AQP1, 2, 4, 5 and 8
function primarily as water-selective transporters, while
AQP3, 7, 9 and 10, termed aquaglyceroporins, transport
water as well as glycerol and other small solutes [7]. The
overexpression of several members of the AQPs family
has been shown to be implicated in tumorigenesis. For
example, AQP5 is overexpressed in breast cancer, cer-
vical cancer and ovarian cancer [8-10]. However, the ex-
pression of AQP5 and AQP8 in CRC and their clinical
significance remain unexplored. To evaluate the poten-
tial of AQP5 and AQP8 as novel prognostic markers of
CRC, we employed RT-PCR and immunohistochemicaltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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clinical samples of CRC and then analyzed the correla-
tions of their expression with the clinicopathological fea-
tures of CRC.
Methods
Patients and tumor samples
From December 2009 to January 2011, samples were
collected from 40 cases of CRC from the Department of
Surgery, the First Affiliated Hospital of Liaoning Medical
University. The clinical samples were obtained from sur-
gically removed, pathologically confirmed CRC. The
patients included 25 men and 15 women and their ages
ranged from 35 to 80 years old. None of the patients
accepted preoperative radiotherapy or chemotherapy
and none of them had hypertension or diabetes. The
pathological classifications of CRC were based on tumor
size, infiltration, differentiation and lymph node metasta-
sis. The matched non-tumor adjacent tissue was
obtained from a segment of the resected specimens that
was the farthest from the tumor (>3 cm). Tissue samples
were snap-frozen in liquid nitrogen and stored at −80°C
until further analysis. The collection of clinical samples
was approved by the Ethics Committee of Liaoning
Medical University, and all patients gave their written
informed consent.
Immunohistochemical staining
Tumor tissues and normal tissues were fixed in 10%
formaldehyde and were paraffin wax-embedded. Subse-
quently, the tissues were cut into 5-μm-thick serial sec-
tions, which were washed carefully with 0.01 M PBS
three times. To block endogenous peroxidases, de-
waxed paraffin sections were treated with 3% hydrogen
peroxide for 20 min. The sections were blocked with
2% goat serum in 0.01 M PBS containing 0.3% Triton
X-100 for 1 h at room temperature, then incubated at
4°C overnight with rabbit antibody against human
AQP5 (1:250 dilution, Bioss Inc., Beijing, China) or
AQP8 (1:200 dilution, Bioss Inc.). Afterwards, the sec-
tions were subjected to immunohistochemical staining
using PV6000 kit (Bioss Inc.). Finally the sections were
developed with diaminobenzidine and assessed by two
independent investigators under light microscopy. The
staining was considered to be positive when a strong
coloration was evident in the membranes of the epithe-
lial cells. Tissues were scored semi-quantitatively by
evaluating the percentage of stained cells of 10 separate
fields. For negative controls, the primary antibodies
were replaced with PBS.
RT-PCR
Total RNA was extracted from the tissues (100 g) using
Trizol (Invitrogen, Carlsbad, CA, USA) following themanufacturer’s protocol. cDNA was produced by reverse
transcription using an RT kit (Takara, Shiga, Japan) fol-
lowing the manufacturer’s protocol. PCR amplification
of AQP5, AQP8 and β-actin was done with Taq Master
Mix(Promega, Madison, WI, USA)with cDNA synthe-
sized from the tissues. The primers used were as follows:
AQP5 50-TGACGAGGACTGGGAGGAGC-30 (forward)
and 50-GGCGGCATTCAATGAACCA-30 (reverse), am-
plicon 488 bp; AQP8 50-TCATTGGAGATGGGAAG
ACC-30 (forward) and 50-TGAGAAGCAAGGAAGTG
GC-30 (reverse), amplicon 437 bp; β-actin 50-GTTC
GCCATGGATGACGATATC-30 (forward) and 50-GCC
AGATCTTCTCCATGTCGTC-30 (reverse), amplicon
128 bp. Amplification conditions were as follows: 5 min
at 95°C (one cycle) and 40 s at 94°C; 40 s at the anneal-
ing temperature (58.5°C for AQP5, 56.8°C for AQP8 and
58.8°C for β-actin); and 1 min at 72°C (35 cycles) and
72°C for 5 min (one cycle). PCR products were analyzed
by 2% gel electrophoresis following densitometric ana-
lysis of band intensity. The relative mRNA levels of
AQP5 and AQP8 were determined with β-actin as the
internal control.
Statistical analysis
The data were expressed as mean (X) ± standard devi-
ation (S). Statistical analysis was performed using
SPSS13.0 software (SPSS, Inc., Chicago, IL, USA) and
P <0.05 was considered significant.
Results
Immunohistochemistry
Immunohistochemical staining detected AQP5 immu-
noreactivity in the cytoplasm and plasma membrane of
colorectal carcinoma cells, but not in the adjacent nor-
mal colorectal tissues. By contrast, AQP8 immunoreac-
tivity was detected in the cytoplasm and plasma
membrane of adjacent normal colon epithelium, but was
not detected in the colorectal carcinoma tissues
(Figure 1).
RT-PCR
Next we performed RT-PCR analysis to detect the ex-
pression of AQP5 and AQP8 at mRNA level in clinical
colorectal samples. The results showed that AQP5
mRNA was abundant in colorectal carcinoma tissue
but undetectable in adjacent normal colon tissue. By
contrast, AQP8 mRNA was abundant in adjacent nor-
mal colon tissue but undetectable in colorectal car-
cinoma tissue (Figure 2). These data are consistent
with the results of immunohistochemical staining and
confirm that the expression of AQP5 is upregulated
but that of AQP8 is downregulated in colorectal
carcinoma.
Figure 1 Representative images of immunohistochemical staining to detect the expression of AQP5 and AQP8 in clinical colorectal
samples. (A) AQP5 immunoreactivity was detected in the cytoplasm and plasma membrane of colorectal carcinoma cells (dark brown). (B) AQP5
immunoreactivity was not detected in the adjacent normal colon epithelium. (C) AQP8 immunoreactivity was detected in the cytoplasm and
plasma membrane of adjacent normal colon epithelium (dark brown). (D) AQP8 immunoreactivity was not detected in the colorectal carcinoma
tissues. (Magnification: ×400).
Table 1 The relationship between AQP5 expression in
colorectal carcinoma and clinicopathological features
Group n AQP5 expression χ2 P
+ -
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clinicopathological features of colorectal carcinoma
To investigate the clinical significance of AQP5 expres-
sion in colorectal carcinoma tissues, we analyzed the
clinicopathological parameters of the patients. Statistical
analysis showed that AQP5 expression was not signifi-
cantly associated with the sex or age of the patients with
CRC (P>0.05), but was closely associated with the differ-
entiation, tumor-nodes-metastasis (TNM) metastasis
stage and distant lymph node metastasis of colorectal
carcinoma (P<0.05) (Table 1).Figure 2 Representative PCR analysis to detect the expression
of AQP5 and AQP8 in clinical colorectal samples. (A) Adjacent
normal colon tissue. (B) Colorectal carcinoma tissue. AQP5 mRNA
was not detected in adjacent normal colon tissue but was abundant
in colorectal carcinoma tissue. By contrast, AQP8 mRNA was
abundant in adjacent normal colon tissue but was not detected in
colorectal carcinoma tissue. β-actin served as the internal control.Discussion
Aquaporins play a crucial role in maintaining water
homeostasis and glycerol metabolism and modulating a
variety of physiological and pathological processes [7].
Significantly, several members of the AQPs family are
involved in tumorigenesis, as suggested by theirGender
Male 25 13 12 0.11 >0.5
Female 15 7 8
Age
≥50 years 28 14 14 0.23 >0.5
<50 years 12 7 5
Differentiation
High and medium 26 18 8 4.66 <0.5
Low 14 5 9
TNM stage
I + II 23 10 13 6.16 <0.5
III + IV 17 14 3
Lymphatic metastasis
Yes 21 7 14 4.91 <0.5
No 19 13 6
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lines [8-10].
AQP5 has been shown to be overexpressed in several
types of cancers and contribute to tumor growth, pro-
gression and metastasis. Consequently, AQP5 has been
proposed as a putative oncogene [11,12]. Recently,
Zhang et al. reported that AQP5 overexpression was sig-
nificantly associated with lymph node involvement and a
poorer prognosis in patients with cervical cancer, sug-
gesting the value of AQP5 as a prognostic marker in cer-
vical cancer [9]. Interestingly, Fischer et al. performed
differential display to find that AQP8 mRNA was
expressed only in normal colonic tissue and not, or to a
much lesser extent, in the adenomas, carcinomas and
cancer cell lines. In situ hybridization demonstrated that
AQP8 was expressed in the cells facing the lumen in the
normal colonic epithelium [13].
The clinical significance of AQP5 and AQP8 in colo-
rectal carcinoma remains largely unexplored. We
employed RT-PCR and immunohistochemical methods
to detect the expression of AQP5 and AQP8 in clinical
samples of colorectal carcinoma and the paraneoplastic
normal colonic tissues. Our results showed that AQP5
was mainly expressed in colorectal carcinoma cells and
barely expressed in paraneoplastic normal tissues. By
contrast, AQP8 was mainly expressed in paraneoplastic
normal tissues and barely expressed in colorectal carcin-
oma cells. The expression patterns of AQP5 and AQP8
in colonic tissues we detected are consistent with the
results of previous studies [13,14]. Furthermore, we ana-
lyzed the correlations of AQP5 expression with the clini-
copathological features of CRC and found that AQP5
expression was not significantly associated with the sex
or age of patients with CRC (P>0.05), but was closely
associated with the differentiation, TNM stage and dis-
tant lymph node metastasis of colorectal carcinoma
(P<0.05). Taken together, our results demonstrate that
AQP5 is upregulated and AQP8 is downregulated in
CRC tissues.
It has been proposed that the expression of AQP8
is a marker of normal proliferating colonic epithelial
cells and suggests these cells to be involved in fluid
transport in the colon [13]. Alternatively, in situ
hybridization demonstrated that the expression of
AQP5 was induced in early-stage disease (early dyspla-
sia) and then maintained through the late stages of
colon cancer development [15]. Therefore, our observa-
tions that AQP8 expression was not detected in colo-
rectal carcinoma while AQP5 expression was closely
associated with the differentiation, TNM stage and dis-
tant lymph node metastasis of colorectal carcinoma
suggest that the loss of AQP8 expression and gain of
AQP5 expression is involved in the process of colorec-
tal carcinogenesis.Notably, it was reported recently that epigallocatechin
gallate, a potential anticancer drug, inhibited the prolifera-
tion and induced the apoptosis of ovarian cancer SKOV3
cells through the downregulation of AQP5 expression
[16]. This study confirmed the overexpression of AQP5 in
CRC and suggested that AQP5 may be a potential thera-
peutic target. Further studies are important to characterize
the potential oncogenic role of AQP5 and antitumor role
of AQP8 in CRC development. Larger samples should be
examined to validate the value of AQP5 as a novel prog-
nostic biomarker for patients with CRC.
Conclusion
AQP5 may be a novel prognostic biomarker for patients
with colorectal carcinoma.
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